Successful clinical trial for re-engineered UQ vaccine: The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved vaccine considered among the best in its class. The pivotal proof-of-concept testing clears the way to progress the promising Clamp2 technology in a range of research programs. Project leader, Associate Professor Keith Chappell, said the preliminary clinical trial results were an exciting reward for the team’s continued dedication and the community’s widespread support for the project. “We compared second-generation clamp SARS-CoV-2 vaccine head-to-head with TGA-approved Nuvaxovid (Novavax), and the two were found to
Successful clinical trial for re-engineered UQ vaccine as seen on The Hippocratic Post.